Clinical Characteristics and Metabolic Predictors of Rapid Responders to Dipeptidyl Peptidase-4 Inhibitor as an Add-on Therapy to Sulfonylurea and Metformin

BACKGROUND: Dipeptidyl peptidase-4 (DPP-4) inhibitor add-on therapy is a new option for patients with inadequately controlled type 2 diabetes who are taking combined metformin and sulfonylurea (SU). We evaluated the efficacy and safety of this triple therapy and the characteristics of rapid responde...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Diabetes Metab J
Main Authors: Kim, Ye An, Yoo, Won Sang, Hong, Eun Shil, Ku, Eu Jeong, Park, Kyeong Seon, Lim, Soo, Cho, Young Min, Park, Kyong Soo, Jang, Hak Chul, Choi, Sung Hee
Formato: Artigo
Idioma:Inglês
Publicado em: Korean Diabetes Association 2015
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4696985/
https://ncbi.nlm.nih.gov/pubmed/26616595
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4093/dmj.2015.39.6.489
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados